Americans’ interest in a potentially harmful ‘magic mushroom’ is soaring, according to a new study. The scientists suggest that the growing market for Amanita muscaria may be sparked in part by emerging clinical research supporting the safety and efficacy of psilocybin as a treatment for depression.
Geiger Mueller News Service